Ministerio de Industria, Turismo y Comercio LogoMinisterior
 

Tecnología para la monitorización y control de Diabetes

Resultados 152 resultados
LastUpdate Última actualización 13/07/2024 [07:11:00]
pdfxls
Solicitudes publicadas en los últimos 60 días / Applications published in the last 60 days
Resultados 1 a 25 de 152 nextPage  

BLOOD GLUCOSE MANAGEMENT METHOD AND RELATED ELECTRONIC DEVICE

NºPublicación:  WO2024146486A1 11/07/2024
Solicitante: 
HUAWEI TECH CO LTD [CN]
\u534E\u4E3A\u6280\u672F\u6709\u9650\u516C\u53F8
WO_2024146486_PA

Resumen de: WO2024146486A1

The present application discloses a blood glucose management method and a related electronic device. According to the method, a meal time of a dietary event of a user can be determined according to a blood glucose value of the user, and when a blood glucose curve drawn according to blood glucose values of the user is displayed, the meal time and/or the blood glucose value associated with the meal time can be displayed on the blood glucose curve. In this way, the dietary event of the user can be associated with the blood glucose of the user, and a blood glucose change condition before and after the user takes a meal is highlighted, so that the user can more visually know the effect of diet on blood glucose, and then the user can manage and control blood glucose starting with the diet.

DELIVERY DEVICE WITH LEAD SCREW INFUSION PUMP

NºPublicación:  US2024226426A1 11/07/2024
Solicitante: 
BECTON DICKINSON AND COMPANY [US]
Becton, Dickinson and Company
JP_2024520403_PA

Resumen de: US2024226426A1

A delivery device (10) for delivering medicament, such as insulin, to a patient includes a barrel (20), a delivery mechanism (12), and a pump assembly (14). The pump assembly includes a plunger (54), a drive member (56) and a drive screw (58). The plunger is able to slide within a barrel of the device independently of the drive plate. In one embodiment, the plunger is able to slide axially on the drive screw. The medication, such as insulin, can be introduced to the barrel (20) to fill the device and force the plunger to move axially in the barrel into engagement of the drive plate. The drive plate has a threaded aperture that mates with the drive screw. The drive plate engages the plunger by rotation of the drive screw to dispense the medication.

AUTOMATICALLY OR MANUALLY INITIATED MEAL BOLUS DELIVERY WITH SUBSEQUENT AUTOMATIC SAFETY CONSTRAINT RELAXATION

NºPublicación:  WO2024147928A1 11/07/2024
Solicitante: 
INSULET CORP [US]
INSULET CORPORATION
WO_2024147928_PA

Resumen de: WO2024147928A1

The exemplary embodiments may provide a drug delivery device that receives glucose level values for a user (e.g., a diabetic patient) and based on the glucose level values, determines when the user has consumed a meal. In some embodiments, the drug delivery device may calculate an appropriate bolus dose and automatically deliver the drug bolus to the user. In some embodiments, instead of detecting the meal, the user may announce the meal, such as by activating an element on the drug delivery device or on a management device for the drug delivery device. Responsive to the meal announcement, the drug delivery device may calculate the drug bolus dose and deliver the drug bolus. In conjunction with the delivery of the drug bolus, the drug delivery device may relax one or more safety constraints for a relaxation period following the drug bolus delivery so that additional basal drug may be delivered, if needed, under relaxed constraints.

SYSTEMS AND METHODS FOR USE OF INSULIN INFORMATION FOR MEAL INDICATION

NºPublicación:  US2024225559A1 11/07/2024
Solicitante: 
ABBOTT DIABETES CARE INC [US]
Abbott Diabetes Care Inc
US_2022287652_PA

Resumen de: US2024225559A1

A system and method provides a glucose report for determining glycemic risk based on an ambulatory glucose profile of glucose data over a time period, a glucose control assessment based on median and variability of glucose, and indicators of high glucose variability. Time of day periods are shown at which glucose levels can be seen. A median glucose goal and a low glucose line provide coupled with glucose variability provide a view into effects that raising or lowering the median goal would have. Likelihood of low glucose, median glucose compared to goal, and variability of glucose below median provide probabilities based on glucose data. Patterns can be seen and provide guidance for treatment.

NON-INVASIVE GLYCATED HEMOGLOBIN OR BLOOD GLUCOSE MEASUREMENT SYSTEM AND METHOD WHICH USE MONTE CARLO SIMULATION

NºPublicación:  US2024233961A1 11/07/2024
Solicitante: 
KOREA I T S CO LTD [KR]
KOREA I.T.S. CO., LTD
KR_20220027515_PA

Resumen de: US2024233961A1

The present disclosure relates to a non-invasive glycated hemoglobin or blood glucose measurement system and method which use a Monte Carlo simulation, wherein the method includes: acquiring a two-dimensional scan image for a specific body part; generating a virtual three-dimensional model corresponding to the specific body part by using the two-dimensional scan image; performing a Monte Carlo simulation (MCS) on the basis of the three-dimensional model; calculating a ratio equation by collecting photoplethysmography (PPG) signals measured according to the Monte Carlo simulation; constructing a mathematical model for glycated hemoglobin or blood glucose measurement on the basis of the ratio equation; and using the mathematical model to calculate the concentration of glycated hemoglobin (HbA1c) or blood glucose and the concentration of oxygen saturation (SpO2) of a measurement subject to be measured.

DECISION SUPPORT AND TREATMENT ADMINISTRATION SYSTEMS

NºPublicación:  US2024233938A1 11/07/2024
Solicitante: 
DEXCOM INC [US]
Dexcom, Inc
JP_2023513805_PA

Resumen de: US2024233938A1

Techniques for data analysis and user guidance are provided for determining and providing one or more treatments to a user based on where the user is or will be in their menstrual cycle. In certain embodiments, a method of personalizing diabetes treatment based on information relating to a menstrual cycle of a user is provided. The method includes measuring, using a glucose monitoring system, blood glucose measurements of the user. The method further includes receiving information relating to the menstrual cycle of the user. The method further includes determining a treatment for the user to achieve a target blood glucose during a sub-phase or phase of the menstrual cycle of the user based on at least one of historical data associated with the user and historical data associated with a stratified group of users.

SENSING SYSTEMS AND METHODS FOR HYBRID GLUCOSE AND KETONE MONITORING

NºPublicación:  US2024225490A1 11/07/2024
Solicitante: 
DEXCOM INC [US]
Dexcom, Inc
WO_2024145651_PA

Resumen de: US2024225490A1

Certain aspects of the present disclosure relate to a monitoring system comprising a continuous analyte sensor configured to generate analyte measurements associated with analyte levels of a patient, and a sensor electronics module coupled to the continuous analyte sensor and configured to receive and process the analyte measurements.

SYSTEMS, DEVICES, AND METHODS RELATING TO MEDICATION DOSE GUIDANCE

NºPublicación:  US2024225535A1 11/07/2024
Solicitante: 
ABBOTT DIABETES CARE INC [US]
ABBOTT DIABETES CARE INC
WO_2024107954_PA

Resumen de: US2024225535A1

Systems, devices and methods are provided for titration of a medication dose for a patient or user. The titration may be based on determining a hypoglycemic risk of a user for a plurality of time-of-day periods. The determination of the hypoglycemic risk may be accomplished by known methods, including the glucose pattern analysis, glucose dysregulation analysis, low alarm frequency analysis, and combinations thereof. The system may then select a recommended action based on the analyte pattern type. The system may then store an indicator of the recommended action in a computer memory for output. The system may then output the recommended action. The recommended action may be outputted to the user, an HCP, or a caregiver. The recommended action may also vary depending on who is receiving the recommended action.

SYSTEM AND METHOD TO MANAGE DIABETES BASED ON GLUCOSE MEDIAN, GLUCOSE VARIABILITY, AND HYPOGLYCEMIC RISK

NºPublicación:  FI3409201T3 11/07/2024
Solicitante: 
ABBOTT DIABETES CARE INC
Abbott Diabetes Care, Inc
US_2022287652_PA

Resumen de: US2024225559A1

A system and method provides a glucose report for determining glycemic risk based on an ambulatory glucose profile of glucose data over a time period, a glucose control assessment based on median and variability of glucose, and indicators of high glucose variability. Time of day periods are shown at which glucose levels can be seen. A median glucose goal and a low glucose line provide coupled with glucose variability provide a view into effects that raising or lowering the median goal would have. Likelihood of low glucose, median glucose compared to goal, and variability of glucose below median provide probabilities based on glucose data. Patterns can be seen and provide guidance for treatment.

ELECTRONIC CIRCUIT AND ANALYTE SENSOR SYSTEM SUCH AS A GLUCOSE SENSOR SYSTEM AND METHOD OF OPERATING AN ANALYTE SENSOR AND SYSTEM

NºPublicación:  AU2023214616A1 11/07/2024
Solicitante: 
F HOFFMANN LA ROCHE AG
F. HOFFMANN-LA ROCHE AG
AU_2023214616_PA

Resumen de: AU2023214616A1

The invention refers to an electronic circuit configured to operate an analyte sensor, such as a glucose sensor, the circuit having at least a first and a second electrical connection configured to be connected to a first and a second electrode of the analyte sensor respectively, wherein the electronic circuit has a voltage source and a common potential conductor section electrically provided on a potential of a pole of the voltage source, wherein with the voltage source an electric potential different to the potential of the common potential conductor section can be provided to the first electrical connection; and wherein the second electrical connection is connected to the common potential conductor section through one or more common potential connection paths and wherein none of the common potential connection paths connects the second electrical connection to the common potential conductor section through fewer than three or more series-connected electronic components.

SYSTEMS, DEVICES, AND METHODS FOR WELLNESS MONITORING WITH PHYSIOLOGICAL SENSORS

NºPublicación:  AU2022425359A1 11/07/2024
Solicitante: 
ABBOTT DIABETES CARE INC
ABBOTT DIABETES CARE INC
AU_2022425359_PA

Resumen de: AU2022425359A1

Systems and methods for monitoring glucose variability in a subject are described. Data indicative of glucose levels of the subject is received from a sensor control device. A first glucose variability metric of the subject in a first time period is determined. The first glucose variability metric may be compared to a threshold. A first indicator is displayed if the first glucose variability metric does not exceed the threshold and a second indicator is displayed if the first glucose variability metric exceeds the threshold. Additional glucose variability metrics may be determined for subsequent time periods according to a rolling window, and the indicators may be displayed real time or in a report. The glucose variability metric may be a measure of variability compared to a baseline, a difference between a maximum and minimum glucose level, or time in or out of a target range

SYSTEMS, DEVICES, AND METHODS TO COMPENSATE FOR TEMPERATURE EFFECTS ON SENSORS

NºPublicación:  AU2021477590A1 11/07/2024
Solicitante: 
DEXCOM INC
DEXCOM, INC
AU_2021477590_PA

Resumen de: AU2021477590A1

Various examples are directed to systems and methods for generating an estimated analyte value, such as a glucose value. An analyte sensor system may access a first sensor signal from an in vivo analyte sensor and a first temperature signal from the ex vivo temperature sensor. The analyte sensor system may generate a first analyte sensor temperature based at least in part on the first temperature signal and generate a first estimated analyte value based at least in part on the first sensor signal and the first temperature-compensated sensitivity. Further examples are directed to using a non-analyte background signal.

AUTOMATICALLY OR MANUALLY INITIATED MEAL BOLUS DELIVERY WITH SUBSEQUENT AUTOMATIC SAFETY CONSTRAINT RELAXATION

NºPublicación:  US2024226433A1 11/07/2024
Solicitante: 
INSULET CORP [US]
INSULET CORPORATION
WO_2024147928_PA

Resumen de: US2024226433A1

The exemplary embodiments may provide a drug delivery device that receives glucose level values for a user (e.g., a diabetic patient) and based on the glucose level values, determines when the user has consumed a meal. In some embodiments, the drug delivery device may calculate an appropriate bolus dose and automatically deliver the drug bolus to the user. In some embodiments, instead of detecting the meal, the user may announce the meal, such as by activating an element on the drug delivery device or on a management device for the drug delivery device. Responsive to the meal announcement, the drug delivery device may calculate the drug bolus dose and deliver the drug bolus. In conjunction with the delivery of the drug bolus, the drug delivery device may relax one or more safety constraints for a relaxation period following the drug bolus delivery so that additional basal drug may be delivered, if needed, under relaxed constraints.

TUBE CONNECTOR FOR AN INFUSION SET

NºPublicación:  WO2024146914A1 11/07/2024
Solicitante: 
UNOMEDICAL AS [DK]
UNOMEDICAL A/S
WO_2024146914_PA

Resumen de: WO2024146914A1

The present disclosure relates to a tube connector (402) for an infusion set, for example for delivering insulin from an insulin pump The tube connector includes a connector body (404) adapted for connection with a tube (406). The tube connector also includes opposing first and second latch arms (412, 414) resiliently joined to the connector body at flexing points (420, 422). The tube connector also includes a first lever (424) attached to the first latch arm and a second lever (426) attached to the second latch arm. The first and second levers extend alongside the first and second latch arms, respectively, such that pressing the first and second levers towards each other deflects the first and second latch arms relative to the body portion about the flexing points.

CONTINUOUS BLOOD SUGAR MEASURING DEVICE

NºPublicación:  EP4397238A2 10/07/2024
Solicitante: 
I SENS INC [KR]
i-Sens, Inc
EP_4397238_PA

Resumen de: EP4397238A2

The present disclosure relates to a continuous blood sugar measuring device, and provides a continuous blood sugar measuring device which is capable of minimizing additional work of a user in order to attach a body attachment unit, by manufacturing the body attachment unit to be assembled inside an applicator so that the body attachment unit can be attached to the body simply by operating the applicator and, particularly: communicating with an external terminal by providing a wireless communication chip in the body attachment unit so that simple and convenient use is possible and maintenance can easily be performed without the additional work of connecting a separate transmitter; initiating operation by a manipulation of the user, after attaching the body attachment unit to the body, so that an operation initiation time can be adjusted to a suitable time according to the need of the user; and initiating operation in a stabilized state to enable a more accurate measurement of blood sugar.

CONTINUOUS BLOOD SUGAR MEASURING DEVICE

NºPublicación:  EP4397237A2 10/07/2024
Solicitante: 
I SENS INC [KR]
i-Sens, Inc
EP_4397237_PA

Resumen de: EP4397237A2

The present disclosure relates to a continuous blood sugar measuring device, and provides a continuous blood sugar measuring device which is capable of minimizing additional work of a user in order to attach a body attachment unit, by manufacturing the body attachment unit to be assembled inside an applicator so that the body attachment unit can be attached to the body simply by operating the applicator and, particularly: communicating with an external terminal by providing a wireless communication chip in the body attachment unit so that simple and convenient use is possible and maintenance can easily be performed without the additional work of connecting a separate transmitter; initiating operation by a manipulation of the user, after attaching the body attachment unit to the body, so that an operation initiation time can be adjusted to a suitable time according to the need of the user; and initiating operation in a stabilized state to enable a more accurate measurement of blood sugar.

LASER-INDUCED GRAPHENE NON-ENZYMATIC GLUCOSE SENSORS FOR ON BODY MEASUREMENTS

NºPublicación:  EP4395643A1 10/07/2024
Solicitante: 
PENN STATE RES FOUND [US]
The Penn State Research Foundation
WO_2023034705_PA

Resumen de: WO2023034705A1

Embodiments relate to a non-enzymatic glucose sensor. The non-enzymatic glucose sensor comprises one or more electrodes, a microfluidic channel, and at least one inlet, wherein the at least one inlet is configured to deliver a fluid to a microfluidic channel and wherein the microfluidic channel is configured to transport the fluid to the one or more electrodes. At least one of the one or more electrodes is a laser-induced graphene electrode, wherein the laser-induced graphene electrode comprises one or more uniform coatings of metal.

SENSOR APPLICATOR ASSEMBLY FOR CONTINUOUS GLUCOSE MONITORING SYSTEM

NºPublicación:  EP4397236A2 10/07/2024
Solicitante: 
I SENS INC [KR]
i-Sens, Inc
EP_4397236_PA

Resumen de: EP4397236A2

The present invention relates to a sensor applicator assembly for a continuous glucose monitoring system and provides a sensor applicator assembly for a continuous glucose monitoring system, which is manufactured with a sensor module assembled inside an applicator, thereby minimizing additional work by a user for attaching the sensor module to the body and allowing the sensor module to be attached to the body simply by operating the applicator, and thus can be used more conveniently. A battery is built in the sensor module and a separate transmitter is connected to the sensor module so as to receive power supply from the sensor module and be continuously used semi-permanently, thereby making the assembly economical. The sensor module and the applicator are used as disposables, thereby allowing accurate and safe use and convenient maintenance.

SENSOR APPLICATOR ASSEMBLY FOR CONTINUOUS GLUCOSE MONITORING SYSTEM

NºPublicación:  EP4397243A2 10/07/2024
Solicitante: 
I SENS INC [KR]
i-Sens, Inc
EP_4397243_PA

Resumen de: EP4397243A2

The present invention relates to a sensor applicator assembly for a continuous glucose monitoring system and provides a sensor applicator assembly for a continuous glucose monitoring system, which is manufactured with a sensor module assembled inside an applicator, thereby minimizing additional work by a user for attaching the sensor module to the body and allowing the sensor module to be attached to the body simply by operating the applicator, and thus can be used more conveniently. A battery is built in the sensor module and a separate transmitter is connected to the sensor module so as to receive power supply from the sensor module and be continuously used semi-permanently, thereby making the assembly economical. The sensor module and the applicator are used as disposables, thereby allowing accurate and safe use and convenient maintenance.

CONTINUOUS BLOOD SUGAR MEASURING DEVICE

NºPublicación:  EP4397239A2 10/07/2024
Solicitante: 
I SENS INC [KR]
i-Sens, Inc
EP_4397239_PA

Resumen de: EP4397239A2

The present disclosure relates to a continuous blood sugar measuring device, and provides a continuous blood sugar measuring device which is capable of minimizing additional work of a user in order to attach a body attachment unit, by manufacturing the body attachment unit to be assembled inside an applicator so that the body attachment unit can be attached to the body simply by operating the applicator and, particularly: communicating with an external terminal by providing a wireless communication chip in the body attachment unit so that simple and convenient use is possible and maintenance can easily be performed without the additional work of connecting a separate transmitter; initiating operation by a manipulation of the user, after attaching the body attachment unit to the body, so that an operation initiation time can be adjusted to a suitable time according to the need of the user; and initiating operation in a stabilized state to enable a more accurate measurement of blood sugar.

Electrically-isolated and moisture-resistant designs for wearable devices

NºPublicación:  US12029553B1 09/07/2024
Solicitante: 
VERILY LIFE SCIENCES LLC [US]
DEXCOM INC [US]
Verily Life Sciences LLC,
DEXCOM, INC
US_12029553_PA

Resumen de: US12029553B1

An example continuous glucose monitor includes a printed circuit board (“PCB”) having first and second outer layers and an inner layer; a semiconductor package having a plurality of pins coupled to the first outer layer of the PCB; an electrical contact formed on the second outer layer of the PCB; a trace having a first portion disposed on the first outer layer, a second portion disposed on the inner layer, and a third portion disposed on the second outer layer, the trace having a first end coupled to a first pin of the plurality of pins and a second end coupled to the electrical contact; and an encapsulant disposed around a perimeter of the semiconductor package, the encapsulant covering the plurality of pins, the first portion of the sensor trace, the third portion of the sensor trace, wherein an upper surface of the semiconductor package remains exposed.

IMPLANT APPARATUS FOR CONTINUOUS BLOOD GLUCOSE MONITOR

NºPublicación:  WO2024138505A1 04/07/2024
Solicitante: 
JIANGSU YUWELL POCT BIOLOGICAL TECH CO LTD [CN]
ZHEJIANG KAILITE MEDICAL INSTR CO LTD [CN]
JIANGSU YUEKAI BIOTECHNOLOGY CO LTD [CN]
\u6C5F\u82CF\u9C7C\u8DC3\u51EF\u7ACB\u7279\u751F\u7269\u79D1\u6280\u6709\u9650\u516C\u53F8,
\u6D59\u6C5F\u51EF\u7ACB\u7279\u533B\u7597\u5668\u68B0\u6709\u9650\u516C\u53F8,
\u6C5F\u82CF\u8DC3\u51EF\u751F\u7269\u6280\u672F\u6709\u9650\u516C\u53F8
WO_2024138505_PA

Resumen de: WO2024138505A1

An implant apparatus for a continuous blood glucose monitor, comprising a housing assembly and a booster core (2) arranged in the housing assembly. The housing assembly comprises a casing (1). An opening is formed at an end of the casing (1). The booster core (2) has a locked state, in which the booster core is fixed relative to the casing (1), and a triggered state, in which the booster core is capable of moving towards the opening. The implant apparatus further comprises a trigger member (3). A side wall of the casing (1) is provided with a guide slideway (11) that extends towards the opening. The trigger member (3) can move along the guide slideway (11) towards the opening and has a first position and a second position relative to the casing (1), causing the booster core (2) to switch from the locked state to the triggered state. The trigger direction of the trigger member (3) faces the opening, and the direction of forces applied by the fingers of a user holding the casing (1) with a hand is radially inward along the casing (1). The force application directions of the two actions are perpendicular to each other, thereby reducing the probability of the user accidentally touching the trigger member (3) when grabbing or holding the casing (1), reducing the risk of the implant apparatus being accidentally triggered, and improving user experience.

BLOOD GLUCOSE MEASUREMENT METHOD, ELECTRONIC DEVICE, AND SYSTEM

NºPublicación:  WO2024140954A1 04/07/2024
Solicitante: 
HUAWEI TECH CO LTD [CN]
\u534E\u4E3A\u6280\u672F\u6709\u9650\u516C\u53F8
WO_2024140954_PA

Resumen de: WO2024140954A1

A blood glucose measurement method, an electronic device (100), and a system. The blood glucose measurement method comprises: first determining a core body temperature, determining a sensor temperature on the basis of the core body temperature, a skin temperature, and physiological parameters, performing temperature compensation for blood glucose measurement, and then obtaining a blood glucose concentration having higher precision.

SENSOR APPLICATOR ASSEMBLY FOR BLOOD GLUCOSE METER

NºPublicación:  WO2024143869A1 04/07/2024
Solicitante: 
I SENS INC [KR]
\uC8FC\uC2DD\uD68C\uC0AC \uC544\uC774\uC13C\uC2A4
WO_2024143869_PA

Resumen de: WO2024143869A1

The present invention provides a sensor applicator assembly for a blood glucose meter, comprising: a body attachment unit including an upper frame and a lower frame disposed below the upper frame and having a surface attached to the body; and an applicator having the body attachment unit disposed therein, wherein the upper frame includes a first area and a second area located below the first area and in contact with the lower frame, and the outer circumference of the second area is the same as the outer circumference of the lower frame.

SENSOR APPLICATOR ASSEMBLY FOR BLOOD GLUCOSE METER

Nº publicación: WO2024143938A1 04/07/2024

Solicitante:

I SENS INC [KR]
\uC8FC\uC2DD\uD68C\uC0AC \uC544\uC774\uC13C\uC2A4

WO_2024143938_PA

Resumen de: WO2024143938A1

The present invention provides a sensor applicator assembly for a blood glucose meter, comprising: an applicator; and a body attachment unit which is disposed in the applicator, and which is composed of a housing including an upper frame and a lower frame, wherein the lower frame has a recessed part formed along the entire circumferential section thereof.

traducir